Discovery of (S)-N-(2-Amino-4-fluorophenyl)-4-(1-(3-(4-((dimethylamino)methyl)phenyl)-6-oxopyridazin-1(6H)-yl)ethyl)benzamide as Potent Class I Selective HDAC Inhibitor for Oral Anticancer Drug Candidate Academic Article
Overview
publication date
- 2023
published in
- Journal of medicinal chemistry Journal
Additional Document Info
start page
- 7016
end page
- 7037
volume
- 66
issue
- 10